Pitavastatin dehydro imp is a structurally related impurity arising from the dehydrogenation of the hydrogenated naphthalene ring in pitavastatin. It features a conjugated diene system in place of the parent compoundβs saturated cyclohexene moiety, retaining the pyrrole-fused core and terminal hydroxyketone functionality. The compound exhibits a planar, rigid conformation due to the double bondβs geometric constraints, differing from pitavastatinβs flexible structure. This impurity likely forms during oxidative synthesis steps or thermal degradation pathways. It serves as a critical HPLC reference standard for quantifying dehydrogenation byproducts in pitavastatin active pharmaceutical ingredient batches.
On Request